Swiss pharma hopes to bounce back from Q1 sales disappointment
Craig Morgan outlines why comparator trials are useful and provides points to consider to ensure the best outcome.
Is the UK’s NHS saving enough from the new wave of biosimilars?
Speaker Interview for Cell & Gene Therapy 2018
Ophthalmic Drugs 2018
Pharmaceutical Freeze Drying Technology – Lyophilisatio